{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:19:59Z","timestamp":1785349199412,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Henan Provincial Medical Science and Technology Research Plan","award":["SBGJ202102175"],"award-info":[{"award-number":["SBGJ202102175"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Radiotherapy is pivotal in treating head and neck cancers including nasopharyngeal, tongue, hypopharyngeal, larynx, maxillary sinus, parotid gland, and oral cancers. It holds the potential for curative effects and finds application in conjunction with chemotherapy, either as a radical method to preserve organ function or as an adjuvant postoperative treatment. We used bioinformatics analysis to investigate the effects of radiotherapy on head and neck cancer tissues in patients who had received radiotherapy. In this study, the expression and mutation profiles of The Cancer Genome Atlas\u2013Head-Neck Squamous Cell Carcinoma were downloaded from the UCSC-Xena database, categorizing patients into two groups\u2014those receiving radiotherapy and those not receiving radiotherapy. Subsequently, differential expression analysis and gene set enrichment analysis (GSEA) were performed. Following this, single-sample GSEA (ssGSEA) scores related to glucose and lipid metabolism were compared between the two groups. Additionally, immune cell infiltration analysis and single-cell verification were performed. Finally, the mutation profiles of the two groups were compared. The analyses revealed that patients receiving radiotherapy exhibited prolonged survival, enhanced apoptosis in head and neck cancer tissue, and diminished keratinocyte proliferation and migration. A comparison of ssGSEA scores related to glucose and lipid metabolism between the two groups indicated a reduction in glycolysis, tricarboxylic acid cycle activity, and fat synthesis in tissues treated with radiotherapy, suggesting that radiotherapy can effectively inhibit tumour cell energy metabolism. Analyses of immune cell infiltration and single-cell verification suggested decreased infiltration of immune cells post-radiotherapy in head and neck cancer tissues. A comparison of mutation profiles revealed a higher frequency of TP53, TTN, and CDKN2A mutations in patients receiving radiotherapy for head and neck cancer. In conclusion, the bioinformatics analyses delved into the effect of radiotherapy on patients with head and neck carcinoma. This study provides a theoretical framework elucidating the molecular mechanisms underlying radiotherapy's efficacy in treating head and neck cancer and presents scientific recommendations for drug therapy following radiotherapy.<\/jats:p>","DOI":"10.1038\/s41598-024-56753-4","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T14:01:48Z","timestamp":1710511308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["RETRACTED ARTICLE: Effect of radiotherapy on head and neck cancer tissues in patients receiving radiotherapy: a bioinformatics analysis-based study"],"prefix":"10.1038","volume":"14","author":[{"given":"Zhenjie","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,15]]},"reference":[{"key":"56753_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4684-5622-6_1","volume":"50","author":"RG Fairchild","year":"1989","unstructured":"Fairchild, R. G. Dose rate and therapeutic gain. Basic Life Sci. 50, 1\u20137. https:\/\/doi.org\/10.1007\/978-1-4684-5622-6_1 (1989).","journal-title":"Basic Life Sci."},{"key":"56753_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.trecan.2019.02.007","volume":"5","author":"JD Horton","year":"2019","unstructured":"Horton, J. D., Knochelmann, H. M., Day, T. A., Paulos, C. M. & Neskey, D. M. Immune evasion by head and neck cancer: Foundations for combination therapy. Trends Cancer. 5, 208\u2013232. https:\/\/doi.org\/10.1016\/j.trecan.2019.02.007 (2019).","journal-title":"Trends Cancer."},{"key":"56753_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson, D. E. et al. Head and neck squamous cell carcinoma. Nat. Rev. Dis. Primers. 6, 92. https:\/\/doi.org\/10.1038\/s41572-020-00224-3 (2020).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"56753_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.canep.2018.10.014","volume":"57","author":"LW Zhang","year":"2018","unstructured":"Zhang, L. W. et al. Incidence and mortality trends in oral and oropharyngeal cancers in China, 2005\u20132013. Cancer Epidemiol. 57, 120\u2013126. https:\/\/doi.org\/10.1016\/j.canep.2018.10.014 (2018).","journal-title":"Cancer Epidemiol."},{"key":"56753_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11864-017-0484-y","volume":"18","author":"SH Huang","year":"2017","unstructured":"Huang, S. H. & O\u2019Sullivan, B. Overview of the 8th edition TNM classification for head and neck cancer. Curr. Treat. Options Oncol. 18, 40. https:\/\/doi.org\/10.1007\/s11864-017-0484-y (2017).","journal-title":"Curr. Treat. Options Oncol."},{"key":"56753_CR6","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1042\/cs20220581","volume":"136","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. CEACAM5 inhibits the lymphatic metastasis of head and neck squamous cell carcinoma by regulating epithelial-mesenchymal transition via inhibiting MDM2. Clin. Sci. 136, 1691\u20131710. https:\/\/doi.org\/10.1042\/cs20220581 (2022).","journal-title":"Clin. Sci."},{"key":"56753_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.soc.2015.03.003","volume":"24","author":"R Georgopoulos","year":"2015","unstructured":"Georgopoulos, R. & Liu, J. C. Examination of the patient with head and neck cancer. Surg. Oncol. Clin. N. Am. 24, 409\u2013421. https:\/\/doi.org\/10.1016\/j.soc.2015.03.003 (2015).","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"56753_CR8","first-page":"251","volume":"25","author":"ME Spector","year":"2018","unstructured":"Spector, M. E., Farlow, J. L., Haring, C. T., Brenner, J. C. & Birkeland, A. C. The potential for liquid biopsies in head and neck cancer. Discov. Med. 25, 251\u2013257 (2018).","journal-title":"Discov. Med."},{"key":"56753_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1056\/NEJMra1715715","volume":"382","author":"LQM Chow","year":"2020","unstructured":"Chow, L. Q. M. Head and neck cancer. N. Engl. J. Med. 382, 60\u201372. https:\/\/doi.org\/10.1056\/NEJMra1715715 (2020).","journal-title":"N. Engl. J. Med."},{"key":"56753_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1053\/j.seminoncol.2019.07.002","volume":"46","author":"D Alterio","year":"2019","unstructured":"Alterio, D. et al. Modern radiotherapy for head and neck cancer. Semin. Oncol. 46, 233\u2013245. https:\/\/doi.org\/10.1053\/j.seminoncol.2019.07.002 (2019).","journal-title":"Semin. Oncol."},{"issue":"Suppl 1","key":"56753_CR11","doi-asserted-by":"publisher","first-page":"E2350","DOI":"10.1002\/hed.24295","volume":"38","author":"AM Bur","year":"2016","unstructured":"Bur, A. M., Lin, A. & Weinstein, G. S. Adjuvant radiotherapy for early head and neck squamous cell carcinoma with perineural invasion: A systematic review. Head Neck. 38(Suppl 1), E2350-2357. https:\/\/doi.org\/10.1002\/hed.24295 (2016).","journal-title":"Head Neck."},{"key":"56753_CR12","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.mayocp.2015.12.017","volume":"91","author":"S Marur","year":"2016","unstructured":"Marur, S. & Forastiere, A. A. Head and neck squamous cell carcinoma: Update on epidemiology, diagnosis, and treatment. Mayo Clin. Proc. 91, 386\u2013396. https:\/\/doi.org\/10.1016\/j.mayocp.2015.12.017 (2016).","journal-title":"Mayo Clin. Proc."},{"issue":"Suppl 10","key":"56753_CR13","doi-asserted-by":"publisher","first-page":"x39","DOI":"10.1093\/annonc\/mdl233","volume":"17","author":"J Bourhis","year":"2006","unstructured":"Bourhis, J., Guigay, J., Temam, S. & Pignon, J. P. Chemo-radiotherapy in head and neck cancer. Ann. Oncol. 17(Suppl 10), x39-41. https:\/\/doi.org\/10.1093\/annonc\/mdl233 (2006).","journal-title":"Ann. Oncol."},{"key":"56753_CR14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/hed.26021","volume":"42","author":"C Du","year":"2020","unstructured":"Du, C. et al. Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma. Head Neck. 42, 426\u2013433. https:\/\/doi.org\/10.1002\/hed.26021 (2020).","journal-title":"Head Neck."},{"key":"56753_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.autrev.2007.11.007","volume":"7","author":"L Stojanovich","year":"2008","unstructured":"Stojanovich, L. & Marisavljevich, D. Stress as a trigger of autoimmune disease. Autoimmun. Rev. 7, 209\u2013213. https:\/\/doi.org\/10.1016\/j.autrev.2007.11.007 (2008).","journal-title":"Autoimmun. Rev."},{"key":"56753_CR16","doi-asserted-by":"publisher","first-page":"105954","DOI":"10.1016\/j.isci.2023.105954","volume":"26","author":"R Wang","year":"2023","unstructured":"Wang, R. et al. Single-cell RNA sequencing reveals the suppressive effect of PPP1R15A inhibitor Sephin1 in antitumor immunity. iScience. 26, 105954. https:\/\/doi.org\/10.1016\/j.isci.2023.105954 (2023).","journal-title":"iScience."},{"key":"56753_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","volume":"24","author":"KPL Bhat","year":"2013","unstructured":"Bhat, K. P. L. et al. Mesenchymal differentiation mediated by NF-\u03baB promotes radiation resistance in glioblastoma. Cancer Cell. 24, 331\u2013346. https:\/\/doi.org\/10.1016\/j.ccr.2013.08.001 (2013).","journal-title":"Cancer Cell."},{"key":"56753_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101082","volume":"4","author":"M Bredel","year":"2023","unstructured":"Bredel, M. et al. Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas. Cell Rep. Med. 4, 101082. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101082 (2023).","journal-title":"Cell Rep. Med."},{"key":"56753_CR19","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41419-019-1769-9","volume":"10","author":"E Alsahafi","year":"2019","unstructured":"Alsahafi, E. et al. Clinical update on head and neck cancer: Molecular biology and ongoing challenges. Cell Death Dis. 10, 540. https:\/\/doi.org\/10.1038\/s41419-019-1769-9 (2019).","journal-title":"Cell Death Dis."},{"key":"56753_CR20","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"56753_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fcell.2019.00052","volume":"7","author":"M Canning","year":"2019","unstructured":"Canning, M. et al. Heterogeneity of the head and neck squamous cell carcinoma immune landscape and its impact on immunotherapy. Front. Cell Dev. Biol. 7, 52. https:\/\/doi.org\/10.3389\/fcell.2019.00052 (2019).","journal-title":"Front. Cell Dev. Biol."},{"key":"56753_CR22","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/cncr.29780","volume":"122","author":"Y Xing","year":"2016","unstructured":"Xing, Y. et al. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma. Cancer. 122, 534\u2013545. https:\/\/doi.org\/10.1002\/cncr.29780 (2016).","journal-title":"Cancer."},{"key":"56753_CR23","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00405-008-0846-y","volume":"266","author":"A Dietz","year":"2009","unstructured":"Dietz, A. et al. Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). Eur. Arch. Otorhinolaryngol. 266, 1291\u20131300. https:\/\/doi.org\/10.1007\/s00405-008-0846-y (2009).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"56753_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.semradonc.2014.11.001","volume":"25","author":"SK Vinod","year":"2015","unstructured":"Vinod, S. K. International patterns of radiotherapy practice for non-small cell lung cancer. Semin. Radiat. Oncol. 25, 143\u2013150. https:\/\/doi.org\/10.1016\/j.semradonc.2014.11.001 (2015).","journal-title":"Semin. Radiat. Oncol."},{"key":"56753_CR25","doi-asserted-by":"publisher","first-page":"20180047","DOI":"10.1259\/bjr.20180047","volume":"92","author":"EL G\u00f6ttgens","year":"2019","unstructured":"G\u00f6ttgens, E. L., Ostheimer, C., Span, P. N., Bussink, J. & Hammond, E. M. HPV, hypoxia and radiation response in head and neck cancer. Br. J. Radiol. 92, 20180047. https:\/\/doi.org\/10.1259\/bjr.20180047 (2019).","journal-title":"Br. J. Radiol."},{"key":"56753_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13046-021-01898-7","volume":"40","author":"SH Wang","year":"2021","unstructured":"Wang, S. H. et al. Insulin-like growth factor binding protein 3 promotes radiosensitivity of oral squamous cell carcinoma cells via positive feedback on NF-\u03baB\/IL-6\/ROS signaling. J. Exp. Clin. Cancer Res. 40, 95. https:\/\/doi.org\/10.1186\/s13046-021-01898-7 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"56753_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbrc.2020.11.022","volume":"537","author":"S Saijoh","year":"2021","unstructured":"Saijoh, S. et al. Discovery of a chemical compound that suppresses expression of BEX2, a dormant cancer stem cell-related protein. Biochem. Biophys. Res. Commun. 537, 132\u2013139. https:\/\/doi.org\/10.1016\/j.bbrc.2020.11.022 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"56753_CR28","doi-asserted-by":"publisher","first-page":"7003","DOI":"10.18632\/aging.204265","volume":"14","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y., Zhang, J., Gong, J., Tang, X. & Zhang, C. UBE2C mediated radiotherapy resistance of head and neck squamous cell carcinoma by regulating oxidative-stress-relative apoptosis. Aging 14, 7003\u20137013. https:\/\/doi.org\/10.18632\/aging.204265 (2022).","journal-title":"Aging"},{"key":"56753_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41389-021-00335-w","volume":"10","author":"L Zhu","year":"2021","unstructured":"Zhu, L. et al. Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: Opportunities and challenges. Oncogenesis. 10, 47. https:\/\/doi.org\/10.1038\/s41389-021-00335-w (2021).","journal-title":"Oncogenesis."},{"key":"56753_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13046-022-02267-8","volume":"41","author":"E Rioja-Blanco","year":"2022","unstructured":"Rioja-Blanco, E. et al. CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma. J. Exp. Clin. Cancer Res. 41, 49. https:\/\/doi.org\/10.1186\/s13046-022-02267-8 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"56753_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.111876","volume":"388","author":"M Huang","year":"2020","unstructured":"Huang, M., Xiong, H., Luo, D., Xu, B. & Liu, H. CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein. Exp. Cell Res. 388, 111876. https:\/\/doi.org\/10.1016\/j.yexcr.2020.111876 (2020).","journal-title":"Exp. Cell Res."},{"key":"56753_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117579","volume":"250","author":"M Xia","year":"2020","unstructured":"Xia, M. et al. Non-coding RNAs: Key regulators of aerobic glycolysis in breast cancer. Life Sci. 250, 117579. https:\/\/doi.org\/10.1016\/j.lfs.2020.117579 (2020).","journal-title":"Life Sci."},{"key":"56753_CR33","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.cmet.2018.02.024","volume":"27","author":"T Cascone","year":"2018","unstructured":"Cascone, T. et al. Increased tumor glycolysis characterizes immune resistance to adoptive T cell therapy. Cell Metab. 27, 977-987.e974. https:\/\/doi.org\/10.1016\/j.cmet.2018.02.024 (2018).","journal-title":"Cell Metab."},{"key":"56753_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/annonc\/mdy507","volume":"30","author":"M Oliva","year":"2019","unstructured":"Oliva, M. et al. Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma. Ann. Oncol. 30, 57\u201367. https:\/\/doi.org\/10.1093\/annonc\/mdy507 (2019).","journal-title":"Ann. Oncol."},{"key":"56753_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12935-020-1104-7","volume":"20","author":"Y She","year":"2020","unstructured":"She, Y. et al. Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma. Cancer Cell Int. 20, 22. https:\/\/doi.org\/10.1186\/s12935-020-1104-7 (2020).","journal-title":"Cancer Cell Int."},{"key":"56753_CR36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/mc.23385","volume":"61","author":"CA Nathan","year":"2022","unstructured":"Nathan, C. A. et al. TP53 mutations in head and neck cancer. Mol. Carcinog. 61, 385\u2013391. https:\/\/doi.org\/10.1002\/mc.23385 (2022).","journal-title":"Mol. Carcinog."},{"key":"56753_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.155","volume":"10","author":"Y Yang","year":"2020","unstructured":"Yang, Y. et al. MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan-cancer. Clin. Transl. Med. 10, e155. https:\/\/doi.org\/10.1002\/ctm2.155 (2020).","journal-title":"Clin. Transl. Med."},{"key":"56753_CR38","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20221168","author":"X Han","year":"2022","unstructured":"Han, X., Chen, J., Wang, J., Xu, J. & Liu, Y. TTN mutations predict a poor prognosis in patients with thyroid cancer. Biosci. Rep. https:\/\/doi.org\/10.1042\/bsr20221168 (2022)."},{"key":"56753_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.molmet.2017.11.012","volume":"8","author":"N Rabhi","year":"2018","unstructured":"Rabhi, N. et al. Cdkn2a deficiency promotes adipose tissue browning. Mol. Metab. 8, 65\u201376. https:\/\/doi.org\/10.1016\/j.molmet.2017.11.012 (2018).","journal-title":"Mol. Metab."},{"key":"56753_CR40","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ccell.2023.05.001","volume":"41","author":"JK Minami","year":"2023","unstructured":"Minami, J. K. et al. CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis. Cancer Cell. 41, 1048-1060.e1049. https:\/\/doi.org\/10.1016\/j.ccell.2023.05.001 (2023).","journal-title":"Cancer Cell."},{"key":"56753_CR41","doi-asserted-by":"publisher","first-page":"A68","DOI":"10.5114\/wo.2014.47136","volume":"19","author":"K Tomczak","year":"2015","unstructured":"Tomczak, K., Czerwi\u0144ska, P. & Wiznerowicz, M. The Cancer Genome Atlas (TCGA): An immeasurable source of knowledge. Contemp. Oncol. (Pozn). 19, A68-77. https:\/\/doi.org\/10.5114\/wo.2014.47136 (2015).","journal-title":"Contemp. Oncol. (Pozn)."},{"key":"56753_CR42","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13073-015-0226-3","volume":"7","author":"H Lee","year":"2015","unstructured":"Lee, H., Palm, J., Grimes, S. M. & Ji, H. P. The Cancer Genome Atlas Clinical Explorer: A web and mobile interface for identifying clinical-genomic driver associations. Genome Med. 7, 112. https:\/\/doi.org\/10.1186\/s13073-015-0226-3 (2015).","journal-title":"Genome Med."},{"key":"56753_CR43","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"56753_CR44","doi-asserted-by":"publisher","first-page":"i555","DOI":"10.1093\/bioinformatics\/bty271","volume":"34","author":"RK Powers","year":"2018","unstructured":"Powers, R. K., Goodspeed, A., Pielke-Lombardo, H., Tan, A. C. & Costello, J. C. GSEA-InContext: Identifying novel and common patterns in expression experiments. Bioinformatics. 34, i555\u2013i564. https:\/\/doi.org\/10.1093\/bioinformatics\/bty271 (2018).","journal-title":"Bioinformatics."},{"key":"56753_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"56753_CR46","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353-d361. https:\/\/doi.org\/10.1093\/nar\/gkw1092 (2017).","journal-title":"Nucleic Acids Res."},{"key":"56753_CR47","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett, T. et al. NCBI GEO: Archive for functional genomics data sets\u2013update. Nucleic Acids Res. 41, D991-995. https:\/\/doi.org\/10.1093\/nar\/gks1193 (2013).","journal-title":"Nucleic Acids Res."},{"key":"56753_CR48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar, R., Domrachev, M. & Lash, A. E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207\u2013210. https:\/\/doi.org\/10.1093\/nar\/30.1.207 (2002).","journal-title":"Nucleic Acids Res."}],"updated-by":[{"DOI":"10.1038\/s41598-025-98250-2","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-56753-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-56753-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-56753-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T04:02:14Z","timestamp":1746936134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-56753-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["56753"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-56753-4","relation":{"references":[{"id-type":"doi","id":"10.1042\/bsr20221168","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]},"assertion":[{"value":"2 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-98250-2","URL":"https:\/\/doi.org\/10.1038\/s41598-025-98250-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6304"}}